Search Results 1351-1360 of 16086 for ozempic

  1. Novel Mitophagy Regulators - Translational Cell Biology of Parkinson's Disease Laboratory - Mayo Clinic Research

    Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic is identifying novel mitophagy regulators and EOPD genes.

  2. News - Rozalina G. McCoy, M.D., M.S. - Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

  3. Lecanemab for Alzheimer's disease: An option for you? - Mayo Clinic

    If you take lecanemab, you need a brain MRI before beginning treatment. Then you have regular MRI scans to check for brain bleeds. If your side effects are ...

  4. A Study of of IW-3718 in Patients with Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of IW-3718 administered to patients with GERD who continue to have persistent symptoms, ...

  5. Examining the efficacy of recombinant zoster vaccination in patients with IBD - Mayo Clinic

    The study also examined the incidence of herpes zoster-related complications, and the impact of IBD medications and comorbidities on infection risks.

  6. Tezacaftor/ivacaftor and ivacaftor (oral route) - Mayo Clinic

    Tezacaftor/ivacaftor and ivacaftor combination is used to treat cystic fibrosis (CF) in patients 6 years of age and older. It is only used for patients who have ...

  7. Atenolol for the Prevention of Osteoporosis (APO) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study to See if Genetic Risk Estimation of Breast Cancer Influences the Use of Preventive Medication - Mayo Clinic

    About this study. The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS), in addition to the standard ...

  9. Early Access Program With Arimoclomol in US Patients With NPC - Mayo Clinic

    NPC is a rare, relentlessly progressive, neurological disease and associated with serious morbidity and shortened life expectancy. Participants will receive ...

  10. Study to Determine Effectiveness of Emotional Disclosure Intervention with Patients and Caregivers - Mayo Clinic

    verbal exercises on physical health and psychosocial health. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, ...